This is about respecting the original stewards of the land who gave this fitting name,” she said. To pass her bill, other ...
Hypersensitivity reactions in a mouse model prompted the agency to suspend Denali’s planned Phase I development for DNL952 ...
Discover why Denali Therapeutics Inc. earns a Strong Buy with FDA-priority drugs, solid pipeline, and a strong cash position.
The FDA has placed a hold on Denali Therapeutics’ plans to launch a phase 1 rare disease trial, citing concerns about immune ...
Zacks Investment Research on MSN
Denali enters into a $275M funding deal with Royalty Pharma
Denali Therapeutics Inc. DNLI has announced a funding agreement with Royalty Pharma plc RPRX for $275 million. The stock ...
Alaska's senior senator is again trying to move mountains to get the White House to restore Denali as the official name of ...
Fintel reports that on December 11, 2025, Wedbush maintained coverage of Denali Therapeutics (NasdaqGS:DNLI) with a ...
Detailed price information for Denali Therapeutics Inc (DNLI-Q) from The Globe and Mail including charting and trades.
Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Jefferies LLC are acting as joint book-running managers for the offering. H.C. Wainwright & Co. is acting as ...
In return, Royalty will receive a 9.25% royalty on worldwide sales of tividenofusp alfa from Denali until it reaches three times the amount Royalty has handed to Denali—or, alternatively, 2.5 times ...
The luxury GMC Denali EV returns for 2026 after its 2024 debut. It is now joined by the lower-cost Elevation and the off-road ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback